| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03d3ecd3adb29b7313f2e5fb0e644139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b16b68d75e995dabe7b9652553b2b28a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b2ef6fb9dbcfb33a48d07baa1371fa7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d29402ca827eac7c7e7518e16611a3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a14244981fdd4a0e48838515951dac |
| publicationDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012009977-A1 |
| titleOfInvention |
FULLY HUMAN TNFα-FAB ANTIBODY AND PEGYLATED ANTIBODY THEREOF |
| abstract |
The present invention discloses a fully human TNFα-Fab antibody and the PEGylated antibody thereof. The amino acid sequence of the light chain variable region of the present fully human TNFα-Fab antibody is SEQ ID NO: 7, and that of the heavy chain variable region is SEQ ID NO: 8. The present invention further discloses the coding gene for said fully human TNFα-Fab antibody, and host cells in which the coding gene is expressed. The present fully human TNFα-Fab antibody can be used to treat inflammations related to TNFα, such as rheumatoid arthritis. |
| priorityDate |
2010-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |